
See exactly how JFNNX's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for JFNNX and 80,000+ other tickers.
This fund endeavors to meet its investment goals by typically committing a minimum of 80% of its net assets (including any borrowed capital used for investment) to companies its portfolio managers determine have a primary focus on life sciences. Moreover, a core tenet of the fund's approach to life science enterprises is a fundamental policy to ordinarily allocate at least 25% of its total assets to businesses formally classified within the "life sciences" sector.
No recent news available.